Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bug

Showing results (281-290 of 320) with videos related to

Pageof 32
Sort By:
British Journal of Haematology|March 23, 2023
Impact of measurable residual disease on outcomes of unrelated donor haematopoietic cell transplantation with post-transplant cyclophosphamide in AML in first complete remissionArnon Nagler, Myriam Labopin, Bhagirathbhai Dholaria, et al.
Transplantation and Cellular Therapy|May 7, 2025
Changes in Chronic Graft-versus-Host Disease Treatment Over Time: A 15-Years Survey Within Allogeneic Hematopoietic Stem Cell Transplant Centers in Germany, Austria, and SwitzerlandAlexander Denk, Matthias Alexander Fante, Silke Heidenreich, et al.
Leukemia|August 6, 2025
Young unrelated donors confer a survival advantage for patients with myeloid malignancies compared to older siblingsJohannes Schetelig, Henning Baldauf, Carina Rave, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 22, 2017
Long-Term Follow-Up and Impact of Comorbidity before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia-Lessons Learned from the Prospective BRIDGE TrialJan Moritz Middeke, Regina Herbst, Stefani Parmentier, et al.
Bone Marrow Transplantation|March 13, 2025
Allogeneic hematopoietic cell transplantation after infection with SARS-CoV-2 during the COVID-19 pandemic: a multicenter retrospective analysisOsama Ahmad, Nicolaus Kröger, Eva Wagner-Drouet, et al.
Annals of Hematology|April 27, 2021
Genome-wide DNA methylation analysis pre- and post-lenalidomide treatment in patients with myelodysplastic syndrome with isolated deletion (5q)Anna Hecht, Julia A Meyer, Johann-Christoph Jann, et al.
Leukemia|August 19, 2015
Clofarabine salvage therapy before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory AML: results of the BRIDGE trialJ M Middeke, R Herbst, S Parmentier, et al.
Transplantation and Cellular Therapy|June 16, 2026
Allogeneic Transplantation in the rare disease MDS/MPN with Neutrophilia: Age and Disease Burden Determine OutcomeAnnemarie Mohring, Katja Sockel, Christian Thiede, et al.
Neuroinformatics|October 24, 2008
The neuroscience information framework: a data and knowledge environment for neuroscienceDaniel Gardner, Huda Akil, Giorgio A Ascoli, et al.
Bone Marrow Transplantation|June 25, 2022
Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia: a study from the ALWP of the EBMTRaynier Devillier, Jacques-Emmanuel Galimard, Myriam Labopin, et al.
Pageof 32

Showing results (281-290 of 320) with videos related to

Sort By:
Pageof 32
British Journal of Haematology|March 23, 2023
Impact of measurable residual disease on outcomes of unrelated donor haematopoietic cell transplantation with post-transplant cyclophosphamide in AML in first complete remissionArnon Nagler, Myriam Labopin, Bhagirathbhai Dholaria, et al.
Transplantation and Cellular Therapy|May 7, 2025
Changes in Chronic Graft-versus-Host Disease Treatment Over Time: A 15-Years Survey Within Allogeneic Hematopoietic Stem Cell Transplant Centers in Germany, Austria, and SwitzerlandAlexander Denk, Matthias Alexander Fante, Silke Heidenreich, et al.
Leukemia|August 6, 2025
Young unrelated donors confer a survival advantage for patients with myeloid malignancies compared to older siblingsJohannes Schetelig, Henning Baldauf, Carina Rave, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 22, 2017
Long-Term Follow-Up and Impact of Comorbidity before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia-Lessons Learned from the Prospective BRIDGE TrialJan Moritz Middeke, Regina Herbst, Stefani Parmentier, et al.
Bone Marrow Transplantation|March 13, 2025
Allogeneic hematopoietic cell transplantation after infection with SARS-CoV-2 during the COVID-19 pandemic: a multicenter retrospective analysisOsama Ahmad, Nicolaus Kröger, Eva Wagner-Drouet, et al.
Annals of Hematology|April 27, 2021
Genome-wide DNA methylation analysis pre- and post-lenalidomide treatment in patients with myelodysplastic syndrome with isolated deletion (5q)Anna Hecht, Julia A Meyer, Johann-Christoph Jann, et al.
Leukemia|August 19, 2015
Clofarabine salvage therapy before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory AML: results of the BRIDGE trialJ M Middeke, R Herbst, S Parmentier, et al.
Transplantation and Cellular Therapy|June 16, 2026
Allogeneic Transplantation in the rare disease MDS/MPN with Neutrophilia: Age and Disease Burden Determine OutcomeAnnemarie Mohring, Katja Sockel, Christian Thiede, et al.
Neuroinformatics|October 24, 2008
The neuroscience information framework: a data and knowledge environment for neuroscienceDaniel Gardner, Huda Akil, Giorgio A Ascoli, et al.
Bone Marrow Transplantation|June 25, 2022
Reduced intensity versus non-myeloablative conditioning regimen for haploidentical transplantation and post-transplantation cyclophosphamide in complete remission acute myeloid leukemia: a study from the ALWP of the EBMTRaynier Devillier, Jacques-Emmanuel Galimard, Myriam Labopin, et al.
Pageof 32